Session 1: Smarter Solid Form & Pre-formulation Studies – Pharma Crystallization Summit

Category : Session 1: Smarter Solid Form & Pre-formulation Studies

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264): A Solid-State Chemistry Perspective

Dr. Alfred Lee, Merck Research Laboratories

What Solid Form Should I Choose?

Ann Newman, Seventh Street Development Group

Understanding and Controlling the API Form/Powder Property Risks in Drug Substance and Product Processes

Dr. Shawn Yin, Bristol Myers Squibb

Absolute Structure Determination of API Molecules by MicroED analysis of Cocrystals formed based on Cocrystal Propensity Prediction Calculations

Drs. Chandler Greenwell (XtalPi), Harsh Shah (J-Star), and Jessica Bruhn (NIS)